PRMT5 facilitates angiogenesis and EMT via HIF-1α/VEGFR/Akt signaling axis in lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PRMT5 facilitates angiogenesis and EMT via HIF-1α/VEGFR/Akt signaling axis in lung cancer

Published:2023-07-03 Issue:13 Volume:15 Page:6163-6178
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Zheng Yonghua¹,Ji Huaxia¹,Yi Wulin¹,Chen Zhanjun¹,Hu Xiaobiao¹,Zhou Jie²,Wang Yang³,Zheng Xiao¹

Affiliation:

1. Department of Pulmonary Medicine, Shanghai Jinshan Tinglin Hospital, Shanghai, P.R. China

2. Dapartment of Pulmonary and Critical Care Medicine, Minhang Hospital, Fudan University, P.R. China

3. Department of Emergency, The 8th People's Hospital of Shanghai, Shanghai, P.R. China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Reference47 articles.

1. Small-cell lung cancer.;De Ruysscher;Lancet,2011

2. Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment.;Molina;Mayo Clin Proc,2019

3. Lung cancer.;Heist;Lancet,2021

4. Research Progress on the Relationship Between Mitochondrial Deoxyguanosine Kinase and Apoptosis and Autophagy in Lung Adenocarcinoma Cells.;Cong;Cancer Insight,2023

5. Mechanical Aspects of Angiogenesis.;Zahler;Cancers (Basel),2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of PRMT1 and PRMT5 in Breast Cancer;International Journal of Molecular Sciences;2024-08-14

2. Epithelial–mesenchymal plasticity in cancer: signaling pathways and therapeutic targets;MedComm;2024-08

3. Targeting PRMT5 enhances the radiosensitivity of tumor cells grown in vitro and in vivo;Scientific Reports;2024-07-27

4. Role and potential therapeutic value of histone methyltransferases in drug resistance mechanisms in lung cancer;Frontiers in Oncology;2024-03-08

5. Inhibition of epigenetic and cell cycle-related targets in glioblastoma cell lines reveals that onametostat reduces proliferation and viability in both normoxic and hypoxic conditions;Scientific Reports;2024-02-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3